Potassium-competitive acid blocker use is associated with a lower risk of renal function deterioration compared to proton pump inhibitor use

被引：0
|
作者：
Jang, Minyoung [1 ]
Jeong, Seoin [1 ]
Kim, Jeongyun [1 ]
Gu, Juyeon [1 ]
Kim, Minji [1 ]
Jeon, Junseok [1 ]
Jang, Hye Ryoun [1 ]
Lee, Jung Eun [1 ]
Huh, Wooseong [1 ]
Lee, Kyungho [1 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.155
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2338
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Potassium-competitive acid blocker use is associated with a lower risk of renal function deterioration compared to proton pump inhibitor use
    Jang, Minyoung
    Jeong, Seoin
    Kim, Jeongyun
    Gu, Juyeon
    Kim, Minji
    Jeon, Junseok
    Jang, Hye Ryoun
    Lee, Jung Eun
    Huh, Wooseong
    Lee, Kyungho
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I277 - I277
  • [2] Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker
    Nagao, Soichiro
    Yabuuchi, Yohei
    Tanaka, Kosuke
    Morihisa, Yoshiki
    Kobayashi, Takuya
    Akiyama, Shinsuke
    Tanke, Gensho
    Wada, Masaya
    Morita, Shuko
    Inoue, Satoko
    Hobyung, Chung
    Yamashita, Daisuke
    Inokuma, Tetsuro
    INTERNAL MEDICINE, 2024, 63 (14) : 2001 - 2010
  • [3] Proton pump inhibitor versus potassium-competitive acid blocker in gastroesophageal reflux disease
    Oshima, Tadayuki
    JGH OPEN, 2024, 8 (06):
  • [4] Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
    Mori, Hideki
    Suzuki, Hidekazu
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 25 (01) : 6 - 14
  • [5] Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects
    Laine, Loren
    Sharma, Prateek
    Mulford, Darcy J.
    Hunt, Barbara
    Leifke, Eckhard
    Smith, Neila
    Howden, Colin W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (07): : 1158 - 1161
  • [6] Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis
    Shirai, Yuichiro
    Kawami, Noriyuki
    Iwakiri, Katsuhiko
    Kuwana, Masataka
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2022, 7 (01) : 57 - 61
  • [7] Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux
    Akiyama, Junichi
    Hosaka, Hiroko
    Kuribayashi, Shiko
    Moriyasu, Shiori
    Hisada, Yuya
    Okubo, Hidetaka
    Watanabe, Kazuhiro
    Imbe, Koh
    Nagata, Naoyoshi
    Kojima, Yasushi
    Yokoi, Chizu
    Uemura, Naomi
    Shimoyama, Yasuyuki
    Kawamura, Osamu
    Yamada, Masanobu
    Kusano, Motoyasu
    DIGESTION, 2020, 101 (02) : 174 - 183
  • [8] PHARMACODYNAMICS AND PHARMACOKINETICS OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN AND THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN HEALTHY US SUBJECTS
    Laine, Loren
    Sharma, Prateek
    Mulford, Darcy J.
    Hunt, Barbara
    Leifke, Eckhard
    Smith, Neila
    Howden, Colin W.
    GASTROENTEROLOGY, 2022, 162 (07) : S543 - S544
  • [9] Effect of potassium competitive acid blocker compared to proton pump inhibitor in gastroesophageal reflux disease
    Wepee, Roderick, Jr.
    Te, Marilyn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 278 - 278
  • [10] The efficacy of potassium-competitive acid blocker compared with high dose of proton pump inhibitor in patients with refractory gastro-esophageal reflux disease
    Lim, N. R.
    Chung, W. C.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
12345